Citation Impact
Citing Papers
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Bronchodilating Effects of Combined Therapy With Clinical Dosages of Ipratropium Bromide and Salbutamol for Stable COPD:
1995
A Comparison of the Effects of Ipratropium Bromide and Metaproterenol Sulfate in Acute Exacerbations of COPD
1990
Pharmacoeconomic Evaluation of COPD
2000
Toward a Consensus Definition for COPD Exacerbations
2000 Standout
Pressure support ventilation via face mask in acute respiratory failure in hypercapnic COPD patients
1993
COPD Guidelines: A Review of the 2018 GOLD Report
2018 Standout
Use of Spirometry for Case Finding, Diagnosis, and Management of Chronic Obstructive Pulmonary Disease (COPD): Evidence Report/Technology Assessment, Number 121
2005
The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
2004 Standout
The Inhaled Bronchodilators Ipratropium Bromide and Metaproterenol in Adults with CF
1989
Global Initiative for Chronic Obstructive Lung Disease
2002 Standout
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
2005 Standout
Lung Cancer: Epidemiology, Etiology, and Prevention
2011 Standout
Noninvasive Ventilation for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
1995 Standout
Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care
2010 Standout
Metagenomic biomarker discovery and explanation
2011 Standout
Inhalation by Nebulization of Albuterol-Ipratropium Combination (Dey Combination) Is Superior to Either Agent Alone in the Treatment of Chronic Obstructive Pulmonary Disease
1998
Dose Response to Ipratropium as a Nebulized Solution in Patients with Chronic Obstructive Pulmonary Disease: A Three-Center Study
1989
Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee
2007 Standout
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Reliability, repeatability and sensitivity to change of externally and self-paced walking tests in COPD patients
2003
Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity
2009 Standout
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis
2004 Standout
New primers for the class Actinobacteria : application to marine and terrestrial environments
2003 Standout
Reducing the Effects of PCR Amplification and Sequencing Artifacts on 16S rRNA-Based Studies
2011 Standout
Results of a multicenter study of nebulized inhalant bronchodilator solutions
1996
Infective endocarditis
2004 Standout
Global burden of COPD: risk factors, prevalence, and future trends
2007 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2001 Standout
Hospitalizations and Mortality in the Lung Health Study
2002
Prognostic Value of Nutritional Status in Chronic Obstructive Pulmonary Disease
1999 Standout
Oxidative Stress in Chronic Obstructive Pulmonary Disease
1997 Standout
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
American Thoracic Society Statement
2003 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Myocarditis
2006 Standout
Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set
2002 Standout
Chronic Obstructive Pulmonary Disease
1992
Whipple's Disease and “Tropheryma whippelii”
2001
Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.
1994
Phylogenetic identification and in situ detection of individual microbial cells without cultivation
1995 Standout
The medically important aerobic actinomycetes: epidemiology and microbiology
1994 Standout
Lymphedema, Lymphocytic Myocarditis, and Sarcoidlike Granulomatosis
1989
Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force
1995
Relation of oxygen uptake to work rate in normal men and men with circulatory disorders
1987
The COPDX Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2003
2003 Standout
Identification of the Uncultured Bacillus of Whipple’s Disease
1992
Endocarditis Due to Rare and Fastidious Bacteria
2001 Standout
Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease.
1996
The Identification of Uncultured Microbial Pathogens
1993
Works of Ashutosh Kumar being referenced
Sarcoidlike granulomas as an early manifestation of Whipple's disease
1984
Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease: A 90-day multi-center study
1986
Effect of Cardiac, Pulmonary, and Vascular Disease on One-Minute Oxygen Uptake
1976
Prospective Study of Controlled Oxygen Therapy
1977